In this episode of #Denatured BioSpace's Lori Ellis sits down with industry leaders to discuss where trials can be improved, such as human and historical diagnosis and screening biases, accessibility, data capturing and more.
#podcast #biospace
hubs.li/Q02sycDP0

On the heels of withdrawing Relyvrio from the U.S. and Canadian markets, Amylyx is now charting a path in Wolfram syndrome with promising interim Phase II data for its lead asset AMX0035.
#biopharma #biospace
hubs.ly/Q02sxnND0

x.com/i/article/1778…

It's been a while since I've been to #AACR but I know that San Diego convention center well. I appreciate my colleagues at BioSpace keeping me in the loop from afar this year. biospace.com/article/aacr-2…

The U.S. Department of Justice has filed a complaint against Regeneron alleging that the pharma knowingly omitted credit card price concessions for Eylea to inflate Medicare reimbursement rates.
#pharma #DOJ #biospace
hubs.ly/Q02sxgHf0

Read about MD Anderson research presented at #AACR24 , including initial clinical data for studies of B-cell non-Hodgkin #lymphoma , #melanoma and #BreastCancer : brnw.ch/21wIH8v BioSpace #EndCancer

Featured in BioSpace, CEO Fady Boctor weighs in on the groundbreaking impact of Opill, the first OTC birth control pill in the US, and the evolution of the birth control market. biospace.com/article/birth-…
#OTCContraception #WomensHealth

Now is not the time for #IRA expansion. Too much is at stake for new medicines and patient health to expand on misguided policies that rely on uncertain and limited evidence. Read more in BioSpace: buff.ly/3vBw2vg

Biopharma Layoff Tracker 2024: Sanofi will eliminate 100 jobs on June 3, Novartis is continuing its deep workforce cuts by announcing plans to eliminate about 680 and Boehringer Ingelheim is cutting its customer-facing salesforce.
#layoffs #biospace
hubs.li/Q02sszzw0

Helix Biostructures offers a full gene-to-structure suite of cryo-EM services that focuses on both quality and fast turnaround/throughput.
#biopharma #biospace
hubs.li/Q02srx8-0

Less than half of cancer drugs approved via the U.S. FDA's accelerated approval pathway between 2013 and 2017 showed clinical benefit in confirmatory trials in terms of overall survival or quality of life, according to the paper.
#fda #biospace
hubs.li/Q02sqcnQ0

While some companies look to AI models to stop revenue leakage in business operations, experts say more fundamental issues must first be addressed.
#AI #data #biospace
hubs.li/Q02sp2Zs0

Many promising small molecules have lost significant investment appeal as a result of lopsided incentives favoring biologics in 2022’s Inflation Reduction Act.
#ira #biospace
hubs.li/Q02sp0vg0

x.com/i/article/1778…

A look at how the #OTC #Opill debut on retail shelves might affect the overall market for #birthcontrol

Birth Control Market Evolves as OTC Opill Hits US Stores | @BioSpace biospace.com/article/birth-… #biopharma #pharma #contraception

x.com/i/article/1778…

Popular #Type2diabetes and #weightlossdrugs do not increase #thyroidcancer risk, according to a new study. Earlier studies and adverse event data suggested these drugs could be associated with an increased risk of thyroid tumors. biospace.com/article/glp-1s… #GLP1 #Ozempic #obesity

Thousands of retail outlets are now receiving shipments of the first over-the-counter birth control pill approved in the U.S., but effects on the overall contraception market are unclear.
#pharma #biospace
hubs.li/Q02snWbM0

Late-stage study results released Tuesday show YS Biopharma’s rabies vaccine candidate can induce twice the seroconversion rate at seven days versus a standard, globally marketed comparator.
#biopharma #biospace
hubs.li/Q02snXLX0

Alphabet Soup: AACR and ACC Dominate Headlines This Week. Join BioSpace's Heather McKenzie, Greg Slabodkin and Tyler for a breakdown of this week's biggest news stories.
#podcast #aacr #aacr 24 #biospace
hubs.li/Q02snWHt0